Hoth Therapeutics Announces Issuance of Chinese Patent for Cancer Cell-Targeting Technology

B Technology Selectively Shuts Down Cancer Reproducing Cells Patent Covers Splice-Switching Oligonucleotide Platform Designed to Induce Apoptosis of Mast Cells NEW YORK, March 31, 2026…

posteditor
posteditor
Articles: 27298

Other News